Deutsche Bank AG Invests $6.11 Million in Teleflex Incorporated $TFX

Deutsche Bank AG acquired a new stake in shares of Teleflex Incorporated (NYSE:TFXFree Report) during the 2nd quarter, according to its most recent 13F filing with the SEC. The firm acquired 48,171 shares of the medical technology company’s stock, valued at approximately $6,106,000.

Several other institutional investors have also recently made changes to their positions in the company. Hsbc Holdings PLC lifted its position in shares of Teleflex by 4.7% during the first quarter. Hsbc Holdings PLC now owns 1,861 shares of the medical technology company’s stock valued at $222,000 after purchasing an additional 84 shares in the last quarter. Banque Cantonale Vaudoise grew its position in Teleflex by 82.5% in the 4th quarter. Banque Cantonale Vaudoise now owns 250 shares of the medical technology company’s stock worth $31,000 after purchasing an additional 113 shares in the last quarter. Hantz Financial Services Inc. grew its position in Teleflex by 40.5% in the 4th quarter. Hantz Financial Services Inc. now owns 392 shares of the medical technology company’s stock worth $48,000 after purchasing an additional 113 shares in the last quarter. UMB Bank n.a. increased its stake in Teleflex by 57.1% in the 4th quarter. UMB Bank n.a. now owns 311 shares of the medical technology company’s stock valued at $38,000 after buying an additional 113 shares during the last quarter. Finally, Maryland State Retirement & Pension System increased its stake in Teleflex by 1.5% in the 4th quarter. Maryland State Retirement & Pension System now owns 8,652 shares of the medical technology company’s stock valued at $1,056,000 after buying an additional 129 shares during the last quarter. Institutional investors own 95.62% of the company’s stock.

Analyst Upgrades and Downgrades

A number of analysts recently commented on TFX shares. Wall Street Zen upgraded Teleflex from a “sell” rating to a “hold” rating in a report on Sunday, August 9th. UBS Group raised their target price on Teleflex from $145.00 to $158.00 and gave the company a “neutral” rating in a research report on Tuesday, August 11th. Mizuho lifted their target price on Teleflex from $140.00 to $145.00 and gave the stock a “neutral” rating in a research note on Wednesday, July 15th. Wells Fargo & Company lifted their target price on Teleflex from $130.00 to $138.00 and gave the stock an “equal weight” rating in a research note on Friday, May 8th. Finally, Needham & Company LLC boosted their price target on shares of Teleflex from $147.00 to $159.00 and gave the stock a “buy” rating in a report on Friday, July 31st. One analyst has rated the stock with a Strong Buy rating, four have assigned a Buy rating, six have given a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat, the company has a consensus rating of “Hold” and a consensus target price of $151.80.

Check Out Our Latest Stock Report on Teleflex

Teleflex Price Performance

Shares of NYSE TFX opened at $138.31 on Tuesday. The firm has a market capitalization of $5.86 billion, a P/E ratio of -5.94, a P/E/G ratio of 0.93 and a beta of 0.81. The company has a quick ratio of 2.12, a current ratio of 2.60 and a debt-to-equity ratio of 0.94. The stock’s 50-day simple moving average is $132.87 and its two-hundred day simple moving average is $125.13. Teleflex Incorporated has a twelve month low of $100.18 and a twelve month high of $145.00.

Teleflex (NYSE:TFXGet Free Report) last posted its quarterly earnings data on Thursday, August 6th. The medical technology company reported $1.76 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.28 by $0.48. Teleflex had a negative net margin of 39.67% and a positive return on equity of 11.93%. The company had revenue of $570.33 million during the quarter, compared to the consensus estimate of $559.59 million. During the same period in the previous year, the firm posted $3.73 EPS. The firm’s revenue was up 28.9% compared to the same quarter last year. Teleflex has set its FY 2026 guidance at 6.900-7.200 EPS. As a group, equities analysts anticipate that Teleflex Incorporated will post 7.26 EPS for the current fiscal year.

Teleflex Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Wednesday, September 30th. Investors of record on Friday, August 14th will be given a dividend of $0.34 per share. This represents a $1.36 annualized dividend and a yield of 1.0%. The ex-dividend date is Friday, August 14th. Teleflex’s dividend payout ratio (DPR) is presently -5.84%.

Teleflex Profile

(Free Report)

Teleflex Incorporated is a diversified global provider of medical technologies, specializing in critical care and surgery. Headquartered in Wayne, Pennsylvania, the company designs, manufactures and distributes devices and solutions used by healthcare professionals in hospital, ambulatory and alternate site settings. Teleflex focuses on delivering products that support complex interventional procedures and improve patient outcomes.

The company’s offerings span several key segments, including Interventional Urology, Respiratory & Anesthesia, Surgical, Cardiac Care, Vascular and Original Equipment Manufacturer (OEM) solutions.

Read More

Want to see what other hedge funds are holding TFX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Teleflex Incorporated (NYSE:TFXFree Report).

Institutional Ownership by Quarter for Teleflex (NYSE:TFX)

Receive News & Ratings for Teleflex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teleflex and related companies with MarketBeat.com's FREE daily email newsletter.